{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:55:00Z","timestamp":1789937700248,"version":"4.0.1"},"reference-count":30,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1210\/jc.2012-3261","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T03:26:06Z","timestamp":1366687566000},"page":"2755-2764","source":"Crossref","is-referenced-by-count":44,"title":["[123I]Iodometomidate Imaging in Adrenocortical Carcinoma"],"prefix":"10.1210","volume":"98","author":[{"given":"Michael C.","family":"Kreissl","sequence":"first","affiliation":[{"name":"Departments of Nuclear Medicine (M.C.K., A.S., H.H., F.A.V., C.R., A.K.B.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schirbel","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (M.C.K., A.S., H.H., F.A.V., C.R., A.K.B.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit (M.F., S.B., B.A., S.H.), Department of Internal Medicine I, University Hospital of Wuerzburg, University of Wuerzburg, D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Haenscheid","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (M.C.K., A.S., H.H., F.A.V., C.R., A.K.B.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik A.","family":"Verburg","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine (F.A.V.), University Hospital of Aachen, Aachen University, D-52074 Aachen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Bock","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit (M.F., S.B., B.A., S.H.), Department of Internal Medicine I, University Hospital of Wuerzburg, University of Wuerzburg, D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Saeger","sequence":"additional","affiliation":[{"name":"Department of Pathology (W.S.), Marienkrankenhaus, D-22087 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Knoedler","sequence":"additional","affiliation":[{"name":"Radiology (P.K.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reiners","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (M.C.K., A.S., H.H., F.A.V., C.R., A.K.B.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine (M.C.K., A.S., H.H., F.A.V., C.R., A.K.B.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Allolio","sequence":"additional","affiliation":[{"name":"Radiology (P.K.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[{"name":"Radiology (P.K.), D-97080 Wuerzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113253002600_B1","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1210\/jc.2008-0050","article-title":"[123I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes","volume":"93","author":"Hahner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-003-1252-8","article-title":"In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats","volume":"30","author":"Mitterhauser","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019041113253002600_B3","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/jm800012w","article-title":"New selective inhibitors of steroid 11\u03b2-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues","volume":"51","author":"Zolle","year":"2008","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2019041113253002600_B4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejrad.2007.10.024","article-title":"Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas","volume":"69","author":"Hennings","year":"2009","journal-title":"Eur J Radiol"},{"key":"key\n\t\t\t\t2019041113253002600_B5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B6","first-page":"972","article-title":"Imaging of adrenal incidentalomas with PET using 11C-metomidate and 18F-FDG","volume":"45","author":"Minn","year":"2004","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-004-1575-0","article-title":"Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11\u03b2-hydroxylase tracer 11C-metomidate","volume":"31","author":"Zettinig","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019041113253002600_B8","first-page":"7","article-title":"Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism","volume":"20","author":"Freitas","year":"1979","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B9","first-page":"897","article-title":"Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism","volume":"20","author":"Gordon","year":"1979","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B10","first-page":"1460","article-title":"Adrenocortical SPECT using iodine-131 NP-59","volume":"39","author":"Hwang","year":"1998","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B11","first-page":"1057","article-title":"SPECT semiquantitative analysis of adrenocortical 131I-6 \u03b2 iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma","volume":"44","author":"La Cava","year":"2003","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MNM.0b013e32834319e3","article-title":"Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios","volume":"32","author":"Maurea","year":"2011","journal-title":"Nucl Med Commun"},{"key":"key\n\t\t\t\t2019041113253002600_B13","first-page":"884","article-title":"The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses","volume":"42","author":"Maurea","year":"2001","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B14","first-page":"1326","article-title":"Efficacy of iodine-131 6\u03b2-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism","volume":"26","author":"Nocaudie-Calzada","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/RLU.0b013e3181f4a16d","article-title":"Adrenal cortical imaging with I-131 NP-59 SPECT-CT","volume":"35","author":"Wong","year":"2010","journal-title":"Clin Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-002-1025-9","article-title":"11C-metomidate PET imaging of adrenocortical cancer","volume":"30","author":"Khan","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019041113253002600_B17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jc.2011-2765","article-title":"[131I]Iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma","volume":"97","author":"Hahner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019041113253002600_B18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2012-3045","article-title":"Functional characterization of adrenal lesions using [123I]IMTO-SPECT\/CT","volume":"98","author":"Hahner","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1524\/ract.92.4.297.35598","article-title":"[123\/131I]Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution","volume":"92","author":"Schirbel","year":"2004","journal-title":"Radiochim Acta"},{"key":"key\n\t\t\t\t2019041113253002600_B20","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2010-0803","article-title":"Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers","volume":"95","author":"Fassnacht","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B21","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00259-010-1471-8","article-title":"18F-FDG PET\/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation","volume":"37","author":"Ansquer","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019041113253002600_B22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acra.2007.01.009","article-title":"Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET\/CT: quantitative and qualitative evaluation","volume":"14","author":"Caoili","year":"2007","journal-title":"Acad Radiol"},{"key":"key\n\t\t\t\t2019041113253002600_B23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients","volume":"94","author":"Groussin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","article-title":"Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography","volume":"91","author":"Leboulleux","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","article-title":"Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma","volume":"91","author":"Mackie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253002600_B26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.rlu.0000124008.68606.4c","article-title":"F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation","volume":"29","author":"Rao","year":"2004","journal-title":"Clin Nucl Med"},{"key":"key\n\t\t\t\t2019041113253002600_B27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1500789","article-title":"18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients","volume":"150","author":"Tenenbaum","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113253002600_B28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113253002600_B29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00613466","article-title":"o,p\u2032-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis","volume":"29","author":"Touitou","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"key\n\t\t\t\t2019041113253002600_B30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.2012-2851","article-title":"Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5a-reductase explaining the need for personalized glucocorticoid and androgen replacement","volume":"98","author":"Chortis","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/7\/2755\/9046991\/jcem2755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:22:08Z","timestamp":1562959328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/7\/2755\/2536985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3261","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}